The trademark application TZIELD was filed by Provention Bio, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on April 23, 2020, and it was registered by office on July 31, 2020 without any oppositions.
The application was filed in English (French was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on January 27, 2021. Appointment and Replacement of representative of the trademark registration was recorded on June 9, 2022. Change of name and professional address of the trademark registration was recorded on August 17, 2022.
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical preparations for the prevention and treatment of diabetes
Pharmaceutical preparations for the prevention and treatment of gastrointestinal diseases
Pharmaceutical preparations for the prevention and treatment of rheumatological diseases
Pharmaceutical preparations for the prevention and treatment of Multiple Sclerosis
Pharmaceutical preparations for use in organ and tissue transplantation
Pharmaceutical preparations for the prevention and treatment of Graft versus Host Disease
Pharmaceutical preparations for the prevention and treatment of Narcolepsy
Pharmaceutical preparations for the prevention and treatment of Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)
Pharmaceutical preparations for the prevention and treatment of Uveitis
Pharmaceutical preparations for the prevention and treatment of Vitiligo
Pharmaceutical preparations for the prevention and treatment of T cell Lymphoma and T cell Leukemia
Pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders and asthma.